SCHEDULE: Morgan Stanley Reduces Evoke Pharma Stake Below 5%
Beneficial Ownership Statement Amendment
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amended Schedule 13G indicating their beneficial ownership of Evoke Pharma Inc. common stock has fallen below the 5% threshold.
Summary
- Morgan Stanley and its wholly-owned subsidiary, Morgan Stanley Smith Barney LLC, filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Evoke Pharma Inc.
- The filing indicates that as of November 30, 2025, both entities ceased to be beneficial owners of more than five percent of Evoke Pharma Inc.'s common stock.
- Their aggregate beneficial ownership is now 31 shares, representing 0.0% of the class of securities.
- The reporting persons hold shared dispositive power over these 31 shares, with no sole or shared voting power, and no sole dispositive power.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine compliance filing reporting a change in institutional ownership, not a performance or strategic announcement by the issuer.
Future Outlook
No forward-looking statements or guidance were provided in this compliance filing.
Industry Context
This is a routine compliance filing for institutional investors, such as Morgan Stanley, to disclose changes in their beneficial ownership of a company's securities when their stake crosses certain regulatory thresholds. It reflects a change in Morgan Stanley's investment position in Evoke Pharma Inc.
Stakeholder Impact
- Shareholders may interpret Morgan Stanley's reduction of its stake to 0.0% as a signal of decreased institutional confidence or a strategic divestment, potentially influencing their own investment decisions.
Key Dates
| Date | Description |
|---|---|
| 11/30/2025 | Date of event requiring the filing, when beneficial ownership fell below 5%. |
| 12/05/2025 | Date of filing of the Schedule 13G Amendment No. 1. |
Keywords
Evoke Pharma, Morgan Stanley, Schedule 13G, beneficial ownership, common stock, institutional ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.